<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2023.1121594</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Machine learning based gray-level co-occurrence matrix early warning system enables accurate detection of colorectal cancer pelvic bone metastases on MRI</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jin</surname>
<given-names>Jinlian</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2135947"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Haiyan</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Shulin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Zhe</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ren</surname>
<given-names>Haibing</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Jinwu</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Xinping</given-names>
</name>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Gezhouba Central Hospital of Sinopharm, The Third Clinical Medical College of China Three Gorges University</institution>, <addr-line>Yichang, Hubei</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: George Matcuk, Cedars Sinai Medical Center, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Xiaolong Wu, Beijing Cancer Hospital, Peking University, China; Brandon K. K. Fields, University of California, San Francisco, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jinlian Jin, <email xlink:href="mailto:jjl7475@163.com">jjl7475@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Gastrointestinal Cancers: Colorectal Cancer, a section of the journal Frontiers in Oncology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1121594</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Jin, Zhou, Sun, Tian, Ren, Feng and Jiang</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Jin, Zhou, Sun, Tian, Ren, Feng and Jiang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>The mortality of colorectal cancer patients with pelvic bone metastasis is imminent, and timely diagnosis and intervention to improve the prognosis is particularly important. Therefore, this study aimed to build a bone metastasis prediction model based on Gray level Co-occurrence Matrix (GLCM) - based Score to guide clinical diagnosis and treatment.</p>
</sec>
<sec>
<title>Methods</title>
<p>We retrospectively included 614 patients with colorectal cancer who underwent pelvic multiparameter magnetic resonance image(MRI) from January 2015 to January 2022 in the gastrointestinal surgery department of Gezhouba Central Hospital of Sinopharm. GLCM-based Score and Machine learning algorithm, that is,artificial neural net7work model(ANNM), random forest model(RFM), decision tree model(DTM) and support vector machine model(SVMM) were used to build prediction model of bone metastasis in colorectal cancer patients. The effectiveness evaluation of each model mainly included decision curve analysis(DCA), area under the receiver operating characteristic (AUROC) curve and clinical influence curve(CIC).</p>
</sec>
<sec>
<title>Results</title>
<p>We captured fourteen categories of radiomics data based on GLCM for variable screening of bone metastasis prediction models. Among them, Haralick_90, IV_0, IG_90, Haralick_30, CSV, Entropy and Haralick_45 were significantly related to the risk of bone metastasis, and were listed as candidate variables of machine learning prediction models. Among them, the prediction efficiency of RFM in combination with Haralick_90, Haralick_all, IV_0, IG_90, IG_0, Haralick_30, CSV, Entropy and Haralick_45 in training set and internal verification set was [AUC: 0.926,95% CI: 0.873-0.979] and [AUC: 0.919,95% CI: 0.868-0.970] respectively. The prediction efficiency of the other four types of prediction models was between [AUC: 0.716,95% CI: 0.663-0.769] and [AUC: 0.912,95% CI: 0.859-0.965].</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The automatic segmentation model based on diffusion-weighted imaging(DWI) using depth learning method can accurately segment the pelvic bone structure, and the subsequently established radiomics model can effectively detect bone metastases within the pelvic scope, especially the RFM algorithm, which can provide a new method for automatically evaluating the pelvic bone turnover of colorectal cancer patients.</p>
</sec>
</abstract>
<kwd-group>
<kwd>colorectal cancer</kwd>
<kwd>bone metastasis</kwd>
<kwd>gray-level co-occurrence matrix</kwd>
<kwd>machine learning</kwd>
<kwd>prediction</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="42"/>
<page-count count="10"/>
<word-count count="4503"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Worldwide, colorectal cancer is still a malignant tumor of the digestive system with a high incidence rate and mortality (<xref ref-type="bibr" rid="B1">1</xref>). In recent years, it is encouraging that advanced diagnostic technologies, such as computed tomography (CT) colon imaging, magnetic resonance imaging (MRI) and positron emission tomography (PET)/CT colon imaging, are beneficial to enable some early cancer patients to receive timely treatment and effectively reduce the recurrence and metastasis rate (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Nevertheless, the poor prognosis caused by colorectal cancer metastasis is still one of the important factors that can not be ignored and avoided.</p>
<p>Previous studies have focused on the common metastatic sites of colorectal cancer, including lymph node metastasis, liver metastasis, and so on (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>). Vigilantly, bone metastasis is also a poor prognostic factor for colorectal cancer, with incidence rate ranging from 2% to 11% (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). As one of the advanced diseases of colorectal cancer, due to the heterogeneity and complexity of bone metastasis, there are great differences in the survival and recurrence of patients (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Previous studies have shown that the most common sites of bone metastasis in colorectal cancer patients are the pelvis, thoracic vertebrae and lumbar vertebrae, while there may be metastatic or implanted small lesions in the pelvis and the pelvic cavity near the sacrum. Cancer emboli can be directly transferred to the pelvis, or transferred to the sacrum through the capillaries of the sacrum, leading to vertebral bone metastasis or other sites (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Therefore, it is urgently needed that the available prediction model can divide patients into different categories according to the risk score of pelvic bone metastasis, so as to select appropriate treatment methods, and can also more accurately evaluate the effectiveness of treatment measures.</p>
<p>Nowadays, radiomics and advanced algorithms have been gradually applied to the medical field, of which the most widely used is clinical prediction model (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Gray level co-occurrence matrix(GLCM) has been widely used in disease diagnosis, clinical staging, treatment evaluation and prognosis evaluation (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). With the help of the spatial correlation characteristics of gray level, the modified technology can describe the image texture, which can efficiently extract and model the features of a variety of medical images (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Additionally, the higher-order algorithm of machine learning, with its iterative weight distribution, can make better use of predictors to improve the diagnostic efficiency of the model.</p>
<p>Inspired by this, this study based on diffusion weighted imaging, on the basis of applying machine learning algorithm to automatically segment the pelvic bone structure, established radiomics model to judge whether there is bone metastasis in the pelvic bone structure of patients with colorectal cancer, in order to better serve clinical decision-making.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Study population</title>
<p>We retrospectively included 614 patients with colorectal cancer who underwent pelvic multiparameter MRI from January 2015 to January 2022 in the gastrointestinal surgery department of Gezhouba Central Hospital of Sinopharm. Comparison against abdominopelvic CT, SPECT/CT, or histopathologic tissue sampling was used to establish the baseline ground truth for presence or absence of bone metastases at the time of enrollment. The inclusion criteria of patients are as follows: (i)Patients suspected of colorectal cancer or undergoing pelvic multi-parametric diffusion weighted imaging(mp-DWI) scan due to reexamination after colorectal cancer treatment; (ii)Patients with complete pelvic DWI images; (iii)Patients without primary pelvic bone disease (primary osteosarcoma, bone cyst, blood system disease, fracture, etc.). Exclusion criteria: (i)Patients with a history of pelvic bone structure surgery; (ii)Patients with a history of other malignancies; (iii)Patients with unsatisfied image quality, such as motion artifacts and chemical shift artifacts; (iv)Patients with incomplete scanning scope and not including most pelvic bone structures. This retrospective study was approved by the Ethics Committee of Gezhouba Central Hospital of Sinopharm, and the research scheme was implemented according to the artificial intelligence(AI) model training specifications of the unit. All patients&#x2019; personal information is encrypted to prevent leakage, and complies with the Declaration of Helsinki. All patients in this study were informed of the study protocol and approved the study by written consent. The process of incorporating patients and building prediction models was shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The flow chart of patient selection and data process.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-13-1121594-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<title>Acquisition of diffusion weighted imaging parameters</title>
<p>We used GE Discovery MR750 W3.0 T machine to perform pelvic MRI plain scan and enhanced scan. The patient was instructed to lie on his back with his head advanced, and the scanning range was from the umbilical foramen level to the pubic symphysis. The sequences included conventional transverse T1WI, (with or without) conventional transverse T2WI, (transverse, sagittal, coronal) fat compression T2WI, (with or without sagittal) transverse DWI (b value=1000s/mm, b value=2000 s/mm), transverse and sagittal fat compression LAVA enhanced sequences. Sagittal fat compression T2WI scanning parameters: TR 4 800.0 ms, TE 110.5 ms, matrix 320 &#xd7; 320, layer thickness and layer spacing are 5&#xa0;mm and 1&#xa0;mm respectively, FOV range: 28&#xa0;cm&#xa0;&#xd7; 28&#xa0;cm.</p>
<p>Next, we standardized the format of DWI, that is, converted the high b value DWI image in DICOM format to Nifty format, and then the radiology resident (with film reading experience of 3 years or more) used ITK-SNAP3.6.0 software(<ext-link ext-link-type="uri" xlink:href="http://www.itksnap.org/pmwiki/pmwiki.php?n=Main.Publications">http://www.itksnap.org/pmwiki/pmwiki.php?n=Main.Publications</ext-link> ) to manually delineate and label the DWI image along the edges of various pelvic bone structures. In addition, a radiologist (with film reading experience &#x2265; 15 years) modified and confirmed the label, and the confirmed image label was used as the gold standard of pelvic bone structure segmentation model.</p>
</sec>
<sec id="s2_3">
<title>Training and verification of segmentation model</title>
<p>We preprocessed the image and extract the texture features, and used the software GE (Shanghai) AK (Artifical Intelligence Kit, V3.2.0R version) application platform to preprocess the image: linear method is used for resampling, with X, Y, Z spacing of 1.000; Gaussian 0.50 is used for noise removal; MR bias field correction is adopted to eliminate the stray intensity change caused by the non-uniformity of magnetic field and coil; Intensity standardization adopts gray discretization, and the expected minimum value and maximum value are 0.015 and 0.255,respectively. After image preprocessing (resampling, offset field correction, intensity standardization), a total of 48 GLCM texture features are finally collected by AK software, including 8 types of parameters, namely: cluster facilitation, cluster shade, correlation, GLCM energy, GLCM entropy, Haralick correlation, inertia, inverse difference motion; 6 angles are calculated, including full angle, full angle SD, 0&#xb0;, 45&#xb0;, 90&#xb0; and 135&#xb0;.</p>
</sec>
<sec id="s2_4">
<title>Analysis and evaluation of pelvic bone metastasis prediction model</title>
<p>We preprocessed the DWI images of 614 patients, namely: size=64 &#xd7; 224 &#xd7; 224 (z, y, x), automatic window width and level. Patients were randomly divided into training set (70%) and verification set (30%) according to 7:3. In order to eliminate the imbalance of the classified training set data, we balance the positive/negative samples by reducing the sampling, and use Min Max to normalize the feature matrix. At the same time, we use Pierce correlation coefficient to reduce the dimension of the data, and the eigenvectors of the transformed eigenmatrix have independent features.</p>
<p>There are four machine learning model building methods used in this study, including artificial neural network model (ANNM), random forest model(RFM), decision tree model(DTM) and support vector machine model (SVMM) (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>). As linear regression models are often used to build clinical prediction models, this study builds generalized linear regression model (GLRM) based on Softmax regression (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>), namely: <inline-formula>
<mml:math display="inline" id="im1">
<mml:mrow>
<mml:mi>&#x3d5;</mml:mi>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:mstyle displaystyle="true">
<mml:msubsup>
<mml:mo>&#x2211;</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msubsup>
<mml:mrow>
<mml:mo>&#x2205;</mml:mo>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:mstyle>
</mml:mrow>
</mml:math>
</inline-formula> RFM, DTM, ANNM and SVM are the most commonly used algorithms in machine learning (<xref ref-type="bibr" rid="B18">18</xref>). In this study, a pelvic bone metastasis prediction model was built based on four supervised learning algorithms.</p>
<p>Before building the prediction model, we use recursive feature elimination algorithm to select features and sort them, and select the first 8 features as the best feature subset; At the same time, for the GLRM, the minimum absolute shrinkage and selection operator classifier are selected to establish a classification model for predicting pelvic bone metastasis based on DWI images (<xref ref-type="bibr" rid="B24">24</xref>). The effectiveness evaluation of each model mainly includes decision curve analysis(DCA) (<xref ref-type="bibr" rid="B25">25</xref>), area under the receiver operating characteristic (AUROC) curve and clinical influence curve(CIC) (<xref ref-type="bibr" rid="B26">26</xref>).</p>
</sec>
<sec id="s2_5">
<title>Statistical methods</title>
<p>The distribution of &#x201c;measurement&#x201d; and &#x201c;counting&#x201d; data in accordance with normal distribution in this study is expressed by means (interquartile interval) and percentage (%). For the independent two sample nonparametric test, the Mann Whitney rank sum test is used for the inter-group comparison that does not meet the normal distribution (<xref ref-type="bibr" rid="B27">27</xref>); The t-test or chi square test is used for the inter group comparison of samples from normal or nearly normal populations. In addition, the visual analysis of all charts in this study was completed with R studio software (download website: <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>); Two tailed P values less than 0.05 were considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Patient baseline data and image segmentation characteristics</title>
<p>According to <italic>Caret</italic> software package algorithm, 614 patients included in this study were randomly divided into training set (N=429,70%) and internal verification set (N=185,30%) according to 7:3. The clinical characteristics and image data sources of patients in the data set were summarized in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. The average age of patients used for pelvic bone structure segmentation model training was 58 (50, 68) years. Among all the patients used to establish the pelvic bone metastasis classification histological model, 53 patients had bone metastasis [average age 55 (47, 65) years], and 561 patients had no bone metastasis [average age 58 (50, 68) years]. In addition, in the split model sample group, there was no statistically significant difference in clinical characteristics (age, pathology, osseous alteration, CEA and tumor location) between the training set and the internal validation set (P&gt;0.05); The three types of GLCM parameters, namely correlation (full angle, 0&#xb0;, 45&#xb0;, 90&#xb0;), inertia (full angle, full angle SD, 0&#xb0;, 45&#xb0;, 90&#xb0;), inverse difference (full angle, 0&#xb0;, 45&#xb0;, 90&#xb0;), cluster prominence and cluster shadow, had statistical differences (P&lt;0.05), while energy, entropy and Haralick correlation had no statistical differences (P&gt;0.05).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Baseline data of patients with colorectal cancer.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Variables</th>
<th valign="middle" align="center">Overall (N=614)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Age (median [IQR]),year</td>
<td valign="middle" align="center">58.00 [49.25, 68.00]</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">sex (%)</th>
</tr>
<tr>
<td valign="top" align="left">Male</td>
<td valign="middle" align="center">381 (62.1)</td>
</tr>
<tr>
<td valign="top" align="left">Female</td>
<td valign="middle" align="center">233 (37.9)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Pathology (%)</th>
</tr>
<tr>
<td valign="top" align="left">Adenocarcinoma</td>
<td valign="middle" align="center">293 (47.7)</td>
</tr>
<tr>
<td valign="top" align="left">Squamous cell carcinoma</td>
<td valign="middle" align="center">231 (37.6)</td>
</tr>
<tr>
<td valign="top" align="left">Adenosquamous carcinoma</td>
<td valign="middle" align="center">61 (9.9)</td>
</tr>
<tr>
<td valign="top" align="left">Small cell carcinoma</td>
<td valign="middle" align="center">29 (4.7)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Tumor stage (%)</th>
</tr>
<tr>
<td valign="top" align="left">I-II</td>
<td valign="middle" align="center">533 (86.8)</td>
</tr>
<tr>
<td valign="top" align="left">III</td>
<td valign="middle" align="center">39 (6.4)</td>
</tr>
<tr>
<td valign="top" align="left">IV</td>
<td valign="middle" align="center">42 (6.8)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Differentiation (%)</th>
</tr>
<tr>
<td valign="top" align="left">High</td>
<td valign="middle" align="center">326 (53.1)</td>
</tr>
<tr>
<td valign="top" align="left">Moderate</td>
<td valign="middle" align="center">189 (30.8)</td>
</tr>
<tr>
<td valign="top" align="left">Low</td>
<td valign="middle" align="center">99 (16.1)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">OA (%)</th>
</tr>
<tr>
<td valign="top" align="left">Osteolytic</td>
<td valign="middle" align="center">393 (64.0)</td>
</tr>
<tr>
<td valign="top" align="left">Osteogenic</td>
<td valign="middle" align="center">188 (30.6)</td>
</tr>
<tr>
<td valign="top" align="left">Miscibility</td>
<td valign="middle" align="center">33 (5.4)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">CEA (%),ng/mL</th>
</tr>
<tr>
<td valign="top" align="left">&lt;100</td>
<td valign="middle" align="center">156 (25.4)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2265;100</td>
<td valign="middle" align="center">458 (74.6)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Tumor location (%)</th>
</tr>
<tr>
<td valign="top" align="left">Colonic segment</td>
<td valign="middle" align="center">197 (32.1)</td>
</tr>
<tr>
<td valign="top" align="left">Rectal segment</td>
<td valign="middle" align="center">417 (67.9)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">ECOG (%)</th>
</tr>
<tr>
<td valign="top" align="left">0-2</td>
<td valign="middle" align="center">278 (45.3)</td>
</tr>
<tr>
<td valign="top" align="left">&gt;2</td>
<td valign="middle" align="center">336 (54.7)</td>
</tr>
<tr>
<td valign="middle" align="left">EV (median [IQR])</td>
<td valign="middle" align="center">0.96 [0.70, 1.22]</td>
</tr>
<tr>
<td valign="middle" align="left">Entropy (median [IQR])</td>
<td valign="middle" align="center">8.63 [8.37, 8.87]</td>
</tr>
<tr>
<td valign="middle" align="left">IG_all (median [IQR])</td>
<td valign="middle" align="center">3.06 [2.62, 3.58]</td>
</tr>
<tr>
<td valign="middle" align="left">IG_0 (median [IQR])</td>
<td valign="middle" align="center">2.20 [1.84, 2.58]</td>
</tr>
<tr>
<td valign="middle" align="left">IG_45 (median [IQR])</td>
<td valign="middle" align="center">2.96 [2.55, 3.39]</td>
</tr>
<tr>
<td valign="middle" align="left">IG_90 (median [IQR])</td>
<td valign="middle" align="center">2.30 [1.81, 2.77]</td>
</tr>
<tr>
<td valign="middle" align="left">IV_all (median [IQR])</td>
<td valign="middle" align="center">186.50 [159.00, 216.75]</td>
</tr>
<tr>
<td valign="middle" align="left">IV_all_SD (median [IQR])</td>
<td valign="middle" align="center">5229.00 [3691.25, 6978.50]</td>
</tr>
<tr>
<td valign="middle" align="left">IV_0 (median [IQR])</td>
<td valign="middle" align="center">159.05 [127.47, 193.60]</td>
</tr>
<tr>
<td valign="middle" align="left">IV_45 (median [IQR])</td>
<td valign="middle" align="center">159.85 [124.62, 192.50]</td>
</tr>
<tr>
<td valign="middle" align="left">IV_90 (median [IQR])</td>
<td valign="middle" align="center">131.00 [108.25, 155.00]</td>
</tr>
<tr>
<td valign="middle" align="left">Haralick_all (median [IQR])</td>
<td valign="middle" align="center">0.10 [0.09, 0.10]</td>
</tr>
<tr>
<td valign="middle" align="left">Haralick_30 (median [IQR])</td>
<td valign="middle" align="center">0.10 [0.09, 0.11]</td>
</tr>
<tr>
<td valign="middle" align="left">Haralick_45 (median [IQR])</td>
<td valign="middle" align="center">0.07 [0.07, 0.08]</td>
</tr>
<tr>
<td valign="middle" align="left">Haralick_90 (median [IQR])</td>
<td valign="middle" align="center">0.11 [0.10, 0.13]</td>
</tr>
<tr>
<td valign="middle" align="left">CSV (median [IQR])</td>
<td valign="middle" align="center">90.00 [84.00, 96.00]</td>
</tr>
<tr>
<td valign="middle" align="left">CP (median [IQR])</td>
<td valign="middle" align="center">79.00 [72.00, 85.00]</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Feature variable screening based on GLCM prediction model</title>
<p>Then, we compared the classification features of bone metastasis lesions based on GLCM between groups, and analyzed the correlation between patients&#x2019; baseline data and candidate variables of bone metastasis. The results showed that Haralick_90, Haralick_all, IV_0, IG_90, IG_0, Haralick_30, CSV, Entropy and Haralick_45 were highly positively correlated with pelvic bone metastasis in colorectal cancer patients (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). In addition, in order to build radiomics model for colorectal cancer patients to conduct classification and evaluation with and without pelvic bone metastasis, we conducted feature extraction from the labeled and segmented images and labels based on the manually labeled and automatically segmented pelvic bone structures, respectively. The extracted features were used to establish the radiomics model, and the processing steps included data equalization, data normalization, feature dimension reduction, and feature selection. As shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>, Haralick_90, IV_0, IG_90, Haralick_30, CSV, Entropy and Haralick_45 were the intersection candidate predictors of RFM, SVM, ANNM and DTM.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Candidate variables related to pelvic bone metastasis in colorectal cancer. <bold>(A)</bold> Correlation between outcome variables of bone metastasis and candidate variables of GLCM; <bold>(B)</bold> Intersection candidate variables of four prediction models based on machine learning algorithm.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-13-1121594-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Construction of bone metastasis model based on generalized linear algorithm</title>
<p>According to the results of multiple logistic regression analysis, a nomograph (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) was developed. The visual quantitative mapping tool of the prediction model was based on the scaling of each regression coefficient to 0 to 100 points in the multiple logistic regression. &#x3b2; The influence of the variable with the highest coefficient (absolute value) is assigned 100 points. Add the scores of all independent variables to get a total, and then convert it into the probability of predicting pelvic bone metastasis. Generally, the C index and AUC value exceeding 0.6 implied a reasonable estimate. This study showed that the C index of GLRM was 0.72, and resampling also showed that the model had an ideal robustness (<xref ref-type="supplementary-material" rid="SF3">
<bold>Figures&#xa0;3B, C</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Construction of GLRM to predict bone metastasis in colorectal cancer patients. <bold>(A)</bold> Prediction score of bone metastasis based on Nomogram visualization; <bold>(B)</bold> Robustness evaluation of GLRM in training set and internal test set; <bold>(C)</bold> Multi-sample model prediction verification based on&#xa0;resampling.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-13-1121594-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Construction of bone metastasis model based on machine learning algorithm</title>
<p>As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM2">
<bold>Supplementary Table&#xa0;2</bold>
</xref>, the RFM based on the &#x201c;bagging&#x201d; algorithm sorted the GLCM parameters, where Haralick_90, Haralick_all, IV_0, IG_90, IG_0, Haralick_30, CSV, Entropy and Haralick_45 were suitable for further model building of the RFM algorithm; The prediction efficiency of the model showed that the model still had a robust and efficient prediction efficiency (AUC: 0.926,95% CI: 0.873-0.979), even though it passed the ten fold cross validation. Consistent with the parameter variables of the RFM model, DTM (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>) adopted CSV, Entropy and Haralick_30 as the decision factors in the &#x201c;branches&#x201d; of the model, and its prediction efficiency in the training set was worse than that of RFM (AUC: 0.889,95% CI: 0.836-0.942); However, ANNM included eight parameters, namely, Entropy, IG_90, IV_0, IV_45, IV_90, Haralick_al, Haralick_30, Haralick_45, Haralick_90 and CSV. The prediction efficiency obtained was AUC: 0.912, 95% CI: 0.859-0.965, which was worse than RFM, but better than DTM, SVM and GLRM.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Construction of bone metastasis prediction model of colorectal cancer based on RFM. <bold>(A)</bold> Sorting of RFM prediction variables based on &#x201c;Pruning&#x201d; algorithm; <bold>(B)</bold> Screening optimal subset based on ten fold fold cross validation; <bold>(C)</bold> Recognition visualization of RFM in differentiating patients with or without pelvic bone metastasis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-13-1121594-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Efficacy evaluation of five bone metastasis prediction models</title>
<p>DCA is a relatively new model evaluation method compared with ROC curve (<xref ref-type="bibr" rid="B28">28</xref>). In this study, we adopted two model effectiveness evaluation methods. We verified the linear regression model GLRM and four machine learning models (RFM, ANNM, SVM and DTM) with an internal test set. From the perspective of prediction accuracy, we can see that RFM has the largest &#x201c;net benefit&#x201d; in DCA(threshold probability=0.81), followed by ANNM, DTM and SVM (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary Table&#xa0;3</bold>
</xref>). GLRM was the least predictive machine learning model, with threshold probability=0.54.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Effectiveness evaluation of five predictive models for pelvic bone metastasis detection based on DCA. <bold>(A)</bold> Training set; <bold>(B)</bold> Internal validation set.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-13-1121594-g005.tif"/>
</fig>
<p>At the same time, the ROC curve showed that the diagnostic efficacy of bone metastasis of RFM in training set and verification set was [AUC: 0.926,95% CI: 0.873-0.979] and [AUC: 0.919,95% CI: 0.868-0.970] respectively, while the diagnostic efficacy of bone metastasis of ANNM in training set and verification set was [AUC: 0.912,95% CI: 0.859-0.965] and [AUC: 0.894,95% CI: 0.843-0.945] respectively, which was slightly lower than that of RFM; As shown in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref> and <xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure&#xa0;2</bold>
</xref>, in general, the prediction efficiency of the prediction model for pelvic metastasis of colorectal cancer constructed by machine learning algorithm was better than that of the traditional generalized linear model. The results were consistent both in the training set and internal test set.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Comparison of predictive efficacy of five types of pelvic bone metastasis prediction models.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" rowspan="2" align="left">Model</th>
<th valign="bottom" colspan="3" align="center">Training set</th>
<th valign="top" colspan="3" align="center">Internal validation set</th>
</tr>
<tr>
<th valign="bottom" align="center">AUC Mean</th>
<th valign="bottom" align="center">AUC 95%CI</th>
<th valign="bottom" align="center">Variables<sup>&amp;</sup>
</th>
<th valign="bottom" align="center">AUC Mean</th>
<th valign="bottom" align="center">AUC 95%CI</th>
<th valign="top" align="center">Variables<sup>&amp;</sup>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">RFM</td>
<td valign="bottom" align="center">0.926</td>
<td valign="bottom" align="center">0.873-0.979</td>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">0.919</td>
<td valign="bottom" align="center">0.868-0.970</td>
<td valign="bottom" align="center">7</td>
</tr>
<tr>
<td valign="bottom" align="left">SVMM</td>
<td valign="bottom" align="center">0.862</td>
<td valign="bottom" align="center">0.809-0.915</td>
<td valign="bottom" align="center">11</td>
<td valign="bottom" align="center">0.841</td>
<td valign="bottom" align="center">0.790-0.892</td>
<td valign="bottom" align="center">11</td>
</tr>
<tr>
<td valign="bottom" align="left">DTM</td>
<td valign="bottom" align="center">0.889</td>
<td valign="bottom" align="center">0.836-0.942</td>
<td valign="bottom" align="center">5</td>
<td valign="bottom" align="center">0.839</td>
<td valign="bottom" align="center">0.788-0.890</td>
<td valign="bottom" align="center">5</td>
</tr>
<tr>
<td valign="bottom" align="left">ANNM</td>
<td valign="bottom" align="center">0.912</td>
<td valign="bottom" align="center">0.859-0.965</td>
<td valign="bottom" align="center">10</td>
<td valign="bottom" align="center">0.894</td>
<td valign="bottom" align="center">0.843-0.945</td>
<td valign="bottom" align="center">10</td>
</tr>
<tr>
<td valign="bottom" align="left">GLRM</td>
<td valign="bottom" align="center">0.716</td>
<td valign="bottom" align="center">0.663-0.769</td>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">0.722</td>
<td valign="bottom" align="center">0.671-0.773</td>
<td valign="bottom" align="center">7</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>&amp;</sup>Variables included in the model.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_6">
<title>Prediction effectiveness evaluation of optimal prediction model</title>
<p>Based on the evaluation of five prediction models for pelvic metastasis of colorectal cancer, we found that RFM was the best in terms of prediction efficiency. In order to further evaluate the differentiation efficiency of RFM, we used CIC to evaluate the &#x201c;classification accuracy&#x201d; of RFM in training set and internal verification set. As shown in <xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>, the blue curve (number high risk with outcome) indicated the number of true positives under each threshold probability, and the red curve (numberhigh risk) indicated the number of people classified as positive (high risk) by the prediction model under each threshold probability. It was credible that RFM can accurately distinguish patients with bone metastasis from those without bone metastasis, whether in training set or internal verification set, which further confirms that RFM can not only increase the interpretability of bone metastasis risk grading model for colorectal cancer patients, but also improve the grading accuracy. Therefore, RFM was suitable for stratified diagnosis and treatment.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Invasion of colorectal cancer has always been a difficult problem in the treatment process. Because cancer cells can metastasize remotely through lymphatic vessels, blood vessels and nerves, especially vascular invasion, that is, cancer cells can metastasize remotely earlier through the portal vein and inferior vena cava (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>). In the early stage of treatment, pay close attention to the degree of colorectal cancer invasion, and carefully check the metastatic lymph nodes (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B32">32</xref>). For those with high degree of invasion or lymph node metastasis, prepare radiotherapy and chemotherapy plans in advance. Routine treatment after radical surgery can have a very important guiding value to improve the prognosis of patients. As far as we know, this is the first attempt to integrate machine learning algorithm and imaging information to build a prediction model for colorectal cancer bone metastasis. Compared with previous studies, this study extracts a series of information that cannot be directly observed by the naked eye through quantitative and high-throughput analysis and processing of medical images, which can better reveal the relationship between tumor biological characteristics and images, and can be used to establish descriptive and predictive models to help doctors make clinical decisions.</p>
<p>At present, studies have found that preoperative T staging, lymphatic metastasis and Duckes staging of colorectal cancer are independent factors that affect the prognosis of colorectal cancer (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>). In addition, anesthesia, perioperative blood transfusion and treatment are also relevant factors. However, most of the above factors are based on liver metastasis and lung metastasis, but there is little analysis on the influencing factors of bone metastasis of colorectal cancer (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B36">36</xref>). There is also a lack of reliable potential indicators that can predict bone metastasis of colorectal cancer. In view of this, this study strives to explore the main influencing factors of bone metastasis after radical resection of colorectal cancer, explore its potential bone metastasis prediction indicators, and build a bone metastasis prediction model based on advanced algorithms. As far as we know, this is the first prediction model for pelvic bone metastasis of colorectal cancer based on radiomics and machine learning. With the help of this model, we hope to better guide clinical diagnosis and treatment.</p>
<p>The bone metastasis of colorectal cancer is mainly osteogenic lesions, with multiple and jumping distribution, and osteogenic changes and osteolytic changes exist at the same time (<xref ref-type="bibr" rid="B37">37</xref>). Fortunately, mpMRI has a high sensitivity and specificity in the diagnosis of colorectal cancer bone metastasis (<xref ref-type="bibr" rid="B38">38</xref>). When both systemic bone phenomena and CT cannot determine the existence of bone metastasis, mpMRI is usually feasible. Generally speaking, mpMRI includes conventional sequences (TIW1 and T2W1) and functional sequences (DWI, DCE-MRI and MRS) (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Among them, DWI is more sensitive to monitoring bone metastasis of colorectal cancer than conventional sequences. DWI is an assessment of microscopic movement of water molecules in the body, and can provide quantitative (such as ADC value) and qualitative (such as signal strength) information for disease diagnosis and treatment.</p>
<p>Radiomics is a new image post-processing technology emerging in recent years. Through quantitative and high-throughput analysis and processing of medical images, it extracts a series of information that cannot be directly observed by the naked eye, reveals the relationship between tumor biological characteristics and images, and is used to establish descriptive and predictive models to help doctors make diagnosis (<xref ref-type="bibr" rid="B40">40</xref>). In this study, on the basis of segmentation of pelvic bone structure, we established radiomics model based on DWI images to detect whether colorectal cancer patients have metastatic lesions within the scope of pelvic bone structure. Encouragingly, the model is robust and accurate in the prediction of test set, which can be used to undertake early warning of colorectal cancer bone metastasis and auxiliary diagnosis before treatment.</p>
<p>With the in-depth development of cross field artificial intelligence machine learning, it is now possible to predict disease risks through machines, and even diagnose some diseases (<xref ref-type="bibr" rid="B41">41</xref>). In recent years, due to the extensive application of deep learning and the inclusion of rich and diverse medical images, it has become an important part of artificial intelligence machine learning diagnosis, so deep learning has also had a huge impact in medical diagnosis. Previous studies have shown that the random forest algorithm can effectively process the mixed data, missing values or outliers, and higher dimensional data in medical data, and then comprehensively classify the data through multiple decision trees, and perform correlation testing, prediction, and interpretation (<xref ref-type="bibr" rid="B42">42</xref>). These processing processes are not easy to appear over fitting, making the prediction accuracy more accurate. In this study, we built and validated the prediction model of colorectal cancer bone metastasis through a large sample size, among which the prediction model established through the random forest (iterative) algorithm was the best (AUC: 0.926,95% CI: 0.873-0.979). In addition, the prediction efficiency of other machine learning models (ANNM, DTM, SVMM) is also better than GLRM. The possible reason is that Logistic regression has advantages in data processing of online relationships, and machine learning is often more applicable in the face of nonlinear problems. Therefore, how to improve the extrapolation of the model needs further research.</p>
<p>In addition, this study inevitably has the following limitations. First of all, this study only judged whether there was bone metastasis in the pelvic cavity at the patient level, and did not discuss the bone structure of a single pelvic cavity or from the focus level. In the future, we should also detect the metastatic lesions at the bone structure level and the lesion level, so as to detect and locate the bone metastasis of colorectal cancer in the pelvic region; Second, this study did not compare the classification performance of the radiomics model with the diagnostic efficacy of radiologists. In the follow-up research, we will compare the effectiveness of artificial intelligence and human experience; Third, this study only used a single DWI sequence to classify whether there is bone metastasis. Although this sequence is essential in the process of bone metastasis detection, it still has some limitations in the detection of osteogenic changes. Therefore, we consider adding other sequences (such as ADC map, T1WI, etc.) to the model in subsequent studies to improve the prediction performance of the model for all types of metastatic lesions.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<title>Conclusion</title>
<p>To sum up, this study based on depth learning segmentation DWI image pelvic bone structure of the radiomics model can better identify the pelvic range of colorectal cancer bone metastases; Among them, the predictive factors provided by RFM combined with GLCM can obtain the best predictive efficacy of bone metastasis, so it can undertake part of the work of mpMRI assisted diagnosis of colorectal cancer, so as to better guide clinical diagnosis and treatment.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>This retrospective study was approved by the Ethics Committee of Gezhouba Central Hospital of Sinopharm, and the research scheme was implemented according to the artificial intelligence(AI) model training specifications of the unit(No. 2020-006). In the informed consent statement of the patient involved in this article. As for oral informed consent, it generally means that if the patient&#x2019;s education level is low or he cannot sign in person(due to either low education level or an inability to sign), the legal guardian designated by the patient will sign on his behalf, while the patient himself has orally declared his informed consent. When we signed this Informed Consent Form, for patients with oral informed consent, it was generally signed by the patient himself and the patient&#x2019;s guardian at the same time, so there was no objection.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>JJ conceived and designed the study and wrote the manuscript. HZ, SS, ZT, HR, JF and XJ collected the data, performed the data analysis, and interpreted the outcome. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank all study participants for consenting to the use of their medical records. The authors also thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fonc.2023.1121594/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fonc.2023.1121594/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.pdf" id="SF1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Image_2.pdf" id="SF2" mimetype="application/pdf"/>
<supplementary-material xlink:href="Image_3.pdf" id="SF3" mimetype="application/pdf"/>
<supplementary-material xlink:href="Table_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_2.docx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_3.docx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>IQR, inter-quartile range; OA, osseous alteration; CEA, carcinoembryonic antigen; ECOG, Eastern Cooperative Oncology Group; EV, Energy value; IG_all, Inverse gap full angle; IG_0, Inverse gap 0&#xb0;; IG_45, Inverse gap 45&#xb0;; IG_90, Inverse gap 90&#xb0;; IV_all, Inertia value full angle; IV_all_SD, Inertia value full angle SD; IV_0, Inertia value 0&#xb0;; IV_45, Inertia value 45&#xb0;; IV_90, Inertia value 90&#xb0;; Haralick_all, Haralick full angle; Haralick_0, Haralick 0&#xb0;; Haralick_30, Haralick 30&#xb0;; Haralick_45, Haralick 45&#xb0;; Haralick_90, Haralick 90&#xb0;; CSV, Cluster shadow value; CP, Cluster prominence.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dekker</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tanis</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Vleugels</surname> <given-names>JLA</given-names>
</name>
<name>
<surname>Kasi</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Wallace</surname> <given-names>MB</given-names>
</name>
</person-group>. <article-title>Colorectal cancer</article-title>. <source>Lancet (London England).</source> (<year>2019</year>) <volume>394</volume>(<issue>10207</issue>):<page-range>1467&#x2013;80</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(19)32319-0</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasseri</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Langenfeld</surname> <given-names>SJ</given-names>
</name>
</person-group>. <article-title>Imaging for colorectal cancer</article-title>. <source>Surg Clinics North America.</source> (<year>2017</year>) <volume>97</volume>(<issue>3</issue>):<page-range>503&#x2013;13</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.suc.2017.01.002</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kijima</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nagata</surname> <given-names>K</given-names>
</name>
<name>
<surname>Utano</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lefor</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Sugimoto</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT</article-title>. <source>World J gastroenterology.</source> (<year>2014</year>) <volume>20</volume>(<issue>45</issue>):<page-range>16964&#x2013;75</page-range>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v20.i45.16964</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Frankel</surname> <given-names>WL</given-names>
</name>
</person-group>. <article-title>Lymph node metastasis in colorectal cancer</article-title>. <source>Surg Oncol Clinics North America.</source> (<year>2018</year>) <volume>27</volume>(<issue>2</issue>):<page-range>401&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.soc.2017.11.011</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Newcomb</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Hardikar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Phipps</surname> <given-names>AI</given-names>
</name>
</person-group>. <article-title>Stage IV colorectal cancer primary site and patterns of distant metastasis</article-title>. <source>Cancer Epidemiol</source> (<year>2017</year>) <volume>48</volume>:<page-range>92&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.canep.2017.04.003</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhullar</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Barriuso</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mullamitha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>MP</given-names>
</name>
<name>
<surname>O'Dwyer</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Aziz</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Biomarker concordance between primary colorectal cancer and its metastases</article-title>. <source>EBioMedicine.</source> (<year>2019</year>) <volume>40</volume>:<page-range>363&#x2013;74</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2019.01.050</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Warner</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>K</given-names>
</name>
<name>
<surname>Raoof</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>GX</given-names>
</name>
<name>
<surname>Kessler</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytoreduction for colorectal metastases: Liver, lung, peritoneum, lymph nodes, bone, brain. when does it palliate, prolong survival, and potentially cure</article-title>? <source>Curr problems surgery.</source> (<year>2018</year>) <volume>55</volume>(<issue>9</issue>):<page-range>330&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1067/j.cpsurg.2018.08.004</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Chun</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>C-K</given-names>
</name>
<name>
<surname>Beom</surname> <given-names>S-H</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical features and KRAS mutation in colorectal cancer with bone metastasis</article-title>. <source>Sci Rep</source> (<year>2020</year>) <volume>10</volume>(<issue>1</issue>):<fpage>21180</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-78253-x</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qian</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>ZC</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>YN</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H-H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L-T</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer</article-title>. <source>Cell communication signaling: CCS.</source> (<year>2021</year>) <volume>19</volume>(<issue>1</issue>):<fpage>9</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12964-020-00667-x</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suresh Babu</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Garg</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lakshmaiah</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Babu</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>RV</given-names>
</name>
<name>
<surname>Loknatha</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Colorectal cancer presenting as bone metastasis</article-title>. <source>J Cancer Res Ther</source> (<year>2017</year>) <volume>13</volume>(<issue>1</issue>):<page-range>80&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/0973-1482.181177</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gou</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: A population-based study</article-title>. <source>Clin Exp metastasis.</source> (<year>2021</year>) <volume>38</volume>(<issue>1</issue>):<fpage>89</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10585-020-10069-5</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madabhushi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Image analysis and machine learning in digital pathology: Challenges and opportunities</article-title>. <source>Med image analysis.</source> (<year>2016</year>) <volume>33</volume>:<page-range>170&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.media.2016.06.037</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Calster</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wynants</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Machine learning in medicine</article-title>. <source>New Engl J Med</source> (<year>2019</year>) <volume>380</volume>(<issue>26</issue>):<fpage>2588</fpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMc1906060</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mumtaz</surname> <given-names>R</given-names>
</name>
<name>
<surname>Shafi</surname> <given-names>U</given-names>
</name>
<name>
<surname>Zaidi</surname> <given-names>SMH</given-names>
</name>
</person-group>. <article-title>Gray Level co-occurrence matrix (GLCM) texture based crop classification using low altitude remote sensing platforms</article-title>. <source>PeerJ Comput science.</source> (<year>2021</year>) <volume>7</volume>:<fpage>e536</fpage>. doi: <pub-id pub-id-type="doi">10.7717/peerj-cs.536</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Pomeroy</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Huo</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>3D-GLCM CNN: A 3-dimensional Gray-level Co-occurrence matrix-based CNN model for polyp classification <italic>via</italic> CT colonography</article-title>. <source>IEEE Trans Med imaging.</source> (<year>2020</year>) <volume>39</volume>(<issue>6</issue>):<page-range>2013&#x2013;24</page-range>. doi: <pub-id pub-id-type="doi">10.1109/TMI.2019.2963177</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naik</surname> <given-names>A</given-names>
</name>
<name>
<surname>Edla</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Dharavath</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Prediction of malignancy in lung nodules using combination of deep, fractal, and Gray-level Co-occurrence matrix features</article-title>. <source>Big data.</source> (<year>2021</year>) <volume>9</volume>(<issue>6</issue>):<page-range>480&#x2013;98</page-range>. doi: <pub-id pub-id-type="doi">10.1089/big.2020.0190</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Song</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps</article-title>. <source>World J gastroenterology.</source> (<year>2020</year>) <volume>26</volume>(<issue>17</issue>):<page-range>2082&#x2013;96</page-range>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v26.i17.2082</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uddin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hossain</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Moni</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Comparing different supervised machine learning algorithms for disease prediction</article-title>. <source>BMC Med Inf decision making.</source> (<year>2019</year>) <volume>19</volume>(<issue>1</issue>):<fpage>281</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12911-019-1004-8</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>RY</given-names>
</name>
<name>
<surname>Coyner</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Kalpathy-Cramer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Introduction to machine learning, neural networks, and deep learning</article-title>. <source>Trans Vision Sci technology.</source> (<year>2020</year>) <volume>9</volume>(<issue>2</issue>):<fpage>14</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1167/tvst.9.2.14</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghiasi</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Zendehboudi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mohsenipour</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>Decision tree-based diagnosis of coronary artery disease: CART model</article-title>. <source>Comput Methods programs biomedicine.</source> (<year>2020</year>) <volume>192</volume>:<fpage>105400</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmpb.2020.105400</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>N</given-names>
</name>
<name>
<surname>Pacheco</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Narrandes</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Applications of support vector machine (SVM) learning in cancer genomics</article-title>. <source>Cancer Genomics proteomics.</source> (<year>2018</year>) <volume>15</volume>(<issue>1</issue>):<fpage>41</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.21873/cgp.20063</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadam</surname> <given-names>VJ</given-names>
</name>
<name>
<surname>Jadhav</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Vijayakumar</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Breast cancer diagnosis using feature ensemble learning based on stacked sparse autoencoders and softmax regression</article-title>. <source>J Med systems.</source> (<year>2019</year>) <volume>43</volume>(<issue>8</issue>):<fpage>263</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s10916-019-1397-z</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>G</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>A novel method of diagnosing premature ventricular contraction based on sparse auto-encoder and softmax regression</article-title>. <source>Bio-medical materials engineering.</source> (<year>2015</year>) <volume>26 Suppl 1</volume>:<page-range>S1549&#x2013;1558</page-range>. doi: <pub-id pub-id-type="doi">10.3233/BME-151454</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alhamzawi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>HTM</given-names>
</name>
</person-group>. <article-title>The Bayesian adaptive lasso regression</article-title>. <source>Math biosciences.</source> (<year>2018</year>) <volume>303</volume>:<fpage>75</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mbs.2018.06.004</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Calster</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wynants</surname> <given-names>L</given-names>
</name>
<name>
<surname>Verbeek</surname> <given-names>JFM</given-names>
</name>
<name>
<surname>Verbakel</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Christodoulou</surname> <given-names>E</given-names>
</name>
<name>
<surname>Vickers</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Reporting and interpreting decision curve analysis: A guide for investigators</article-title>. <source>Eur urology.</source> (<year>2018</year>) <volume>74</volume>(<issue>6</issue>):<fpage>796</fpage>&#x2013;<lpage>804</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.eururo.2018.08.038</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>N</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>He</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Predicting 30-days mortality for MIMIC-III patients with sepsis-3: A machine learning approach using XGboost</article-title>. <source>J Trans Med</source> (<year>2020</year>) <volume>18</volume>(<issue>1</issue>):<fpage>462</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-020-02620-5</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fay</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Malinovsky</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Confidence intervals of the Mann-Whitney parameter that are compatible with the wilcoxon-Mann-Whitney test</article-title>. <source>Stat Med</source> (<year>2018</year>) <volume>37</volume>(<issue>27</issue>):<fpage>3991</fpage>&#x2013;<lpage>4006</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.7890</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vickers</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Holland</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Decision curve analysis to evaluate the clinical benefit of prediction models</article-title>. <source>Spine journal: Off J North Am Spine Society.</source> (<year>2021</year>) <volume>21</volume>(<issue>10</issue>):<page-range>1643&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.spinee.2021.02.024</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piawah</surname> <given-names>S</given-names>
</name>
<name>
<surname>Venook</surname> <given-names>AP</given-names>
</name>
</person-group>. <article-title>Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer</article-title>. <source>Cancer.</source> (<year>2019</year>) <volume>125</volume>(<issue>23</issue>):<page-range>4139&#x2013;47</page-range>. doi: <pub-id pub-id-type="doi">10.1002/cncr.32163</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertocchi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carloni</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ravenda</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Bertalot</surname> <given-names>G</given-names>
</name>
<name>
<surname>Spadoni</surname> <given-names>I</given-names>
</name>
<name>
<surname>Cascio</surname> <given-names>AL</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver</article-title>. <source>Cancer Cell</source> (<year>2021</year>) <volume>39</volume>(<issue>5</issue>):<fpage>708</fpage>&#x2013;<lpage>724.e711</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ccell.2021.03.004</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tauriello</surname> <given-names>DV</given-names>
</name>
<name>
<surname>Calon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lonardo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Batlle</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Determinants of metastatic competency in colorectal cancer</article-title>. <source>Mol Oncol</source> (<year>2017</year>) <volume>11</volume>(<issue>1</issue>):<fpage>97</fpage>&#x2013;<lpage>119</lpage>. doi: <pub-id pub-id-type="doi">10.1002/1878-0261.12018</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebbeh&#xf8;j</surname> <given-names>AL</given-names>
</name>
<name>
<surname>J&#xf8;rgensen</surname> <given-names>LN</given-names>
</name>
<name>
<surname>Krarup</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>HG</given-names>
</name>
</person-group>. <article-title>Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis</article-title>. <source>Br J surgery.</source> (<year>2021</year>) <volume>108</volume>(<issue>7</issue>):<page-range>769&#x2013;76</page-range>. doi: <pub-id pub-id-type="doi">10.1093/bjs/znab168</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kawada</surname> <given-names>K</given-names>
</name>
<name>
<surname>Obama</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>(<issue>15</issue>):<page-range>112&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.3390/ijms22158002</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messersmith</surname> <given-names>WA</given-names>
</name>
</person-group>. <article-title>NCCN guidelines updates: Management of metastatic colorectal cancer</article-title>. <source>J Natl Compr Cancer Network: JNCCN.</source> (<year>2019</year>) <volume>17</volume>(<issue>5.5</issue>):<fpage>599</fpage>&#x2013;<lpage>601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.6004/jnccn.2019.5014</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>ZW</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>ZY</given-names>
</name>
</person-group>. <article-title>Application and progress of texture analysis in the therapeutic effect prediction and prognosis of neoadjuvant chemoradiotherapy for colorectal cancer</article-title>. <source>Chin Med Sci J</source> (<year>2019</year>) <volume>34</volume>(<issue>1</issue>):<fpage>45</fpage>&#x2013;<lpage>50</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.24920/003572</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allgayer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Leupold</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Patil</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Defining the "Metastasome": Perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences</article-title>. <source>Semin Cancer Biol</source> (<year>2020</year>) <volume>60</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.semcancer.2019.07.018</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paauwe</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schoonderwoerd</surname> <given-names>MJA</given-names>
</name>
<name>
<surname>Helderman</surname> <given-names>R</given-names>
</name>
<name>
<surname>Harryvan</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Groenewoud</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pelt</surname> <given-names>GWv</given-names>
</name>
<etal/>
</person-group>. <article-title>Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis</article-title>. <source>Clin Cancer research: an Off J Am Assoc Cancer Res</source> (<year>2018</year>) <volume>24</volume>(<issue>24</issue>):<page-range>6331&#x2013;44</page-range>. doi: <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-0329</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xfc;rses</surname> <given-names>B</given-names>
</name>
<name>
<surname>B&#xf6;ge</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alt&#x131;nmakas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bal&#x131;k</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Multiparametric MRI in rectal cancer</article-title>. <source>Diagn interventional Radiol (Ankara Turkey).</source> (<year>2019</year>) <volume>25</volume>(<issue>3</issue>):<page-range>175&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.5152/dir.2019.18189</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>S</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>A clinical-radiomics model incorporating T2-weighted and diffusion-weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer</article-title>. <source>Med physics.</source> (<year>2021</year>) <volume>48</volume>(<issue>9</issue>):<page-range>4872&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.1002/mp.15001</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>The application of magnetic resonance imaging (MRI) for the prediction of surgical outcomes in trigeminal neuralgia</article-title>. <source>Postgraduate Med</source> (<year>2022</year>) <volume>134</volume>(<issue>5</issue>):<page-range>480&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1080/00325481.2022.2067612</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deo</surname> <given-names>RC</given-names>
</name>
</person-group>. <article-title>Machine learning in medicine</article-title>. <source>Circulation.</source> (<year>2015</year>) <volume>132</volume>(<issue>20</issue>):<page-range>1920&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.001593</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savargiv</surname> <given-names>M</given-names>
</name>
<name>
<surname>Masoumi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Keyvanpour</surname> <given-names>MR</given-names>
</name>
</person-group>. <article-title>A new random forest algorithm based on learning automata</article-title>. <source>Comput Intell Neurosci</source> (<year>2021</year>) <volume>2021</volume>:<fpage>5572781</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2021/5572781</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>